PM Jan Arogya Yojna: ICMR drafts treatment guidelines for better healthcare

Photo: Shutterstock

In order to provide better healthcare facilities, the National Health Authority (NHA) has adopted the Standard Treatment Guidelines (STGs) for their claim at adjudication. These STGs have been framed by the Indian Council of Medical Research Institute (ICMR).

For this, NHA and ICMR are continuously discussing the modalities and strategies to develop the adoption and implementation of STGs in the Aysuhman Bharat-Prime Minister Jan Arogya Yojna (AB-PMJAY), which is the biggest healthcare scheme in the world that provides a cover of Rs 5 lakh per family per year to around 50 crore poor and vulnerable individuals.

"So far, the ICMR has developed STGs for 30 treatment modalities like cataract, COPD, hysterectomy, hemodialysis, emergency management of ureteric stones, respiratory failure due to any cause, PTCA, systemic thrombolysis, coronary artery bypass grafting (CABG), low cardiac output IABP inspection post-operatively, asthma, epilepsy, stroke, D & C (dilatation and curettage), etc. NHA has adopted these STGs in the scheme and would likely to increase in future," a senior official at NHA told ANI.

"It will be beneficial for the patients so that they get treatment as per the standardised guidelines. It will be beneficial for doctors as they can get away from the hassles of medico-legal cases. Hospitals would know the type of treatment and what are the requirements for consumables and drugs. This will also allow insurance experts to fulfill all norms of STGs in their healthcare packages as drafted by ICMR," said the official.

The apex medical research body has defined STGs as standard treatment schedules, standard treatment protocols or therapeutic guidelines, are systematically developed statements designed to assist practitioners and patients in making informed decisions about suitable healthcare for specific clinical conditions.

According to ICMR, these STGs are used worldwide to prevent the misuse of medicines through the improper treatment of common problems and to encourage the economically efficient and therapeutic effective usage of medicines.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel